Moody’s upgrades Hercules Capital’s senior unsecured rating to Baa2

Moody's Ratings has upgraded Hercules Capital, Inc.'s long-term issuer and senior unsecured debt ratings to Baa2 from Baa3, with a stable outlook, citing the company's consistent strong profitability, superior asset quality, and low leverage. Hercules Capital's net income to average managed assets ratio of 6.7% significantly outperforms its peer median of 4.6%, supported by a debt-to-equity leverage of 0.97x (including SBA debentures) and a diverse funding profile. While acknowledging concentration risk in venture and life sciences lending (top 10 exposures at 28.6%), the stable outlook reflects expectations for continued outperformance and disciplined financial management.

Analysis

Moody's Ratings has upgraded Hercules Capital, Inc. (HTGC) to a Baa2 rating with a stable outlook, affirming the company's strong fundamental performance and conservative financial management. The upgrade is anchored by superior profitability metrics, including a net income to average managed assets ratio of 6.7% for the year ending June 30, 2025, which significantly exceeds the peer median of 4.6%. The company's balance sheet strength is demonstrated by its low leverage, with debt-to-equity at 0.97x, and a substantial asset coverage ratio cushion of 48%, ranking it among the highest of rated Business Development Companies (BDCs). Furthermore, HTGC's diverse funding profile, with a low secured debt to assets ratio of 7.2%, and ample liquidity to cover all unfunded commitments, provides a significant operational buffer. The primary credit challenge identified is the portfolio's concentration in venture-backed technology and life sciences firms, where the top ten exposures represent a relatively high 28.6% of total investments. However, the stable outlook suggests confidence that HTGC's management will continue to navigate this risk while sustaining its outperformance in profitability and balance sheet discipline.

Key Decisions for Investors

• Investors should view the Moody's upgrade to Baa2 as a strong validation of Hercules Capital's superior credit quality and profitability, potentially warranting a more favorable position relative to BDC peers with weaker metrics.
• The primary risk to monitor is the high concentration in venture-backed technology and life sciences, where the top ten investments represent 28.6% of the portfolio, making the company's performance sensitive to downturns in these specific sectors.
• Given the strong balance sheet with leverage at 0.97x and an ample 48% asset coverage cushion, debt investors may find HTGC's paper increasingly attractive, while equity investors should assess if the current valuation fully reflects these enhanced credit fundamentals and sector-leading profitability.